Spruce, Xeraya hold first close of biotech Fund II – update

The joint venture between Spruce Capital Partners and Xeraya Capital has closed MLS Capital Fund II on $150m.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.